Quoin Pharmaceuticals develops topical drug candidates for rare genetic skin diseases, led by a lotion for Netherton Syndrome. It last closed at $3.28 on Nov 20, down 2.35% on the day. The next earnings report for QNRX is expected around Thu, Mar 25, 2027. Over its last 8 reports the stock moved an average of 5.8% the session after earnings. Over the last 12 months QNRX insiders bought $280K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is QNRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold QNRX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on QNRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
QNRX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 16% below its 20 day and 41% below its 50 day average. It is 72% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the swing low (Jun 23) at $3.25, and the nearest resistance the Pivot at $3.37.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 10.0%/day
Key levels
$23.5052 week high+616.5%
$5.65200 day average+72.3%
$4.89100 day average+49.1%
$4.6450 day average+41.5%
$3.99Swing high (Nov 13)+21.6%
$3.8120 day average+16.2%
$3.55Pivot R1+8.2%
$3.37Pivot+2.7%
$3.28Last close
$3.25Swing low (Jun 23)−0.9%
$3.1852 week low−3.0%
$3.09Pivot S1−5.8%
Indicators
RSI (14)
32.69
Weak, oversold below 30
Neutral
MACD
-0.31
Below its signal line
Bearish
Stochastic
13.1
Near the bottom of its range
Oversold
ADX (14)
24.5
Weak trend
Williams %R
-91.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-139.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−10.1%
Change over 10 sessions
Bearish
ATR (14)
$0.33
Typical daily range, 10.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 37.1%/day
Key levels
$23.5052 week high+616.5%
$5.65200 day average+72.3%
$4.89100 day average+49.1%
$4.6450 day average+41.5%
$3.99Swing high (Nov 13)+21.6%
$3.8120 day average+16.2%
$3.55Pivot R1+8.2%
$3.37Pivot+2.7%
$3.28Last close
$3.25Swing low (Jun 23)−0.9%
$3.1852 week low−3.0%
$3.09Pivot S1−5.8%
Indicators
RSI (14)
36.92
Weak, oversold below 30
Neutral
MACD
-0.73
Below its signal line
Bearish
Stochastic
3.8
Near the bottom of its range
Oversold
ADX (14)
13.6
No clear trend
Williams %R
-98.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-111.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−51.7%
Change over 10 sessions
Bearish
ATR (14)
$1.22
Typical daily range, 37.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for QNRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how QNRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow QNRX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for QNRXHow many large options trades hit QNRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in QNRX in the last 90 days.
From SEC Form 4 filings by QNRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether QNRX is in one of them and how their past QNRX trades turned out.
Quoin Pharmaceuticals is a specialty drug developer based in Ashburn, Virginia. It focuses on treatments for rare and orphan diseases that have few or no approved options. Its lead product candidate, QRX003, is a topical lotion in clinical testing for Netherton Syndrome, a rare genetic skin disease, and it is also being studied for other rare skin conditions. The company plans to sell its products to patients and healthcare providers in the United States, Europe and Japan, and works with distribution partners in other countries. It has not yet commercialized any products.